Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease

This publication has 12 references indexed in Scilit:

• Asp57-negative HLA DQβ chain and DQA1*0501 allele are essential for the onset of DQw2-positive and DQw2-negative coeliac disease
  Clinical and Experimental Immunology, 2008
• T cells from the small intestinal Mucosa of a DR4, DQ7/DR4. DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8
  Human Immunology, 1994
• T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1∗0501, β1∗0201) heterodimer
  Human Immunology, 1994
• Wheat peptide challenge in coeliac disease
  The Lancet, 1994
• Celiac disease among Ashkenazi Jews from Israel
  Human Immunology, 1993
• Gluten Stimulation of Coeliac Mucosa In Vitro Induces Activation (CD25) of Lamina Propria CD4^H T cells and Macrophages but no Crypt‐Cell Hyperplasia
  Scandinavian Journal of Immunology, 1993
• HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis
  Gastroenterology, 1993
• Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
  The Journal of Experimental Medicine, 1993
• HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7
  Human Immunology, 1992
• Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.
  The Journal of Experimental Medicine, 1989